|Preferred IUPAC name
|Systematic IUPAC name
3D model (JSmol)
|Molar mass||144.26 g·mol−1|
|Boiling point||228 °C (442 °F; 501 K)|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Octamoxin (trade names Ximaol, Nimaol), also known as 2-octylhydrazine, is an irreversible and nonselective monoamine oxidase inhibitor (MAOI) of the hydrazine class that was used as an antidepressant in the 1960s but is now no longer marketed.
- "Octamoxin - Compound Summary". USA: National Center for Biotechnology Information. 26 March 2005. Identification and Related Records. Retrieved 31 May 2012.
- "Dictionary of pharmacological agents - Google Books".
- "13-06781. Octamoxin [Archived]: The Merck Index".
- Levy J, Michel-Ber E (1966). "[Relations between the antidepressive effects of octamoxine revealed by 3 pharmacological tests and inhibition of cerebral monoamine oxidase in mice]". Thérapie (in French). 21 (4): 929–45. PMID 5925088.
- Gayral L, Stern H, Puyuelo R (1966). "[Indications and results of the treatment of mental depression by octamoxine (ximaol)]". Thérapie (in French). 21 (5): 1183–90. PMID 5976767.
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|